Trademark Overview
On Wednesday, September 19, 2007, a trademark application was filed for TRIOL with the United States Patent and Trademark Office. The USPTO has given the TRIOL trademark a serial number of 77283239. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, August 23, 2008. This trademark is owned by Hollis-Eden Pharmaceuticals, Inc.. The TRIOL trademark is filed in the Pharmaceutical Products category with the following description:
(Based on Intent to Use) Anti-diabetic pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma
